• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDICAL COMPONENTS, INC.; SPLIT CATH II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDICAL COMPONENTS, INC.; SPLIT CATH II Back to Search Results
Model Number UNKNOWN
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Local Reaction (2035); Sepsis (2067); Thromboembolism (2654)
Event Type  malfunction  
Manufacturer Narrative
Information provided shows the medcomp device is the split cath ii.We assume this is a typographical error and the reporter is referring to the split cath iii.Limited information was provided regarding the article.Title, author, and date of publication or the location of the study were not provided making any further investigation on our part impossible.As the article refers to multiple devices from multiple manufacturers resulting in multiple patient reactions but does not indicate which device is involved in which reactions, we are not able to review complaint history.Without further details of the study we are unable to investigate the issue further.
 
Event Description
According to the literature, a retrospective cohort study between 2012 and 2018 was undertaken to determine the infection free survival rate of tunneled cuffed catheters (tcc), the incidence and causes of catheter failure, and the associated risk factors in children undergoing maintenance hemodialysis through tunneled catheters.Forty-five (45) tccs were inserted in patients between the ages of 5 and 16.Either a silicone mahurkar catheter in sizes 8, 10, or 12.5 fr was used or a competitor device.Nine deaths were reported where 3 died due to catheter related blood stream infection (crbsi) associated sepsis and 6 due to causes unrelated to the catheter.Serious complications included infection in 15 patients where the organism of infection was either gram negative bacilli, klebsiella, pseudomonas, mrsa, citrobacter, acinetobacter, or candida glabra.Infections were treated with either antibiotics or catheter removal.Thrombosis occurred in 13 patients.Thrombosis was treated with either urokinase locking solutions, recombinant-urokinase infusions, or catheter removal.Non-serious complications included 2 kinking and malposition of catheters which were either managed with wire manipulation or catheter removal and 3 catheters that were cracked were removed and replaced with another catheter.The authors do not provide information on which reported adverse events are related to mathurkar catheters or a competitor device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK
Type of Device
SPLIT CATH II
Manufacturer (Section D)
MEDICAL COMPONENTS, INC.
1499 delp drive
harleysville PA 19438
Manufacturer (Section G)
MEDICAL COMPONENTS, INC.
1499 delp drive
harleysville PA 19438
Manufacturer Contact
lynn winkler
1499 delp drive
harleysville, PA 19438
2152564201
MDR Report Key18426140
MDR Text Key332614066
Report Number2518902-2024-00001
Device Sequence Number1
Product Code MSD
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 01/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberUNKNOWN
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/28/2023
Date Manufacturer Received12/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-